CS
RCKT icon

Candriam SCA’s Rocket Pharmaceuticals RCKT Stock Holding History

Candriam SCA’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-165,000
Closed -$4.45M – 720
2024
Q1 		$4.45M Buy
165,000
+55,000
+50% +$1.56M 0.03% 360
2023
Q4 		$3.3M Buy
110,000
+60,000
+120% +$1.32M 0.02% 399
2023
Q3 		$1.02M Hold
50,000
– – 0.01% 551
2023
Q2 		$994K Hold
50,000
– – 0.01% 603
2023
Q1 		$788K Hold
50,000
– – 0.01% 721
2022
Q4 		$978K Buy
+50,000
New +$921K 0.01% 700
2021
Q2 		– Sell
-128,749
Closed -$6.78M – 930
2021
Q1 		$6.78M Hold
128,749
– – 0.06% 321
2020
Q4 		$7.06M Buy
+128,749
New +$4.69M 0.06% 329

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return